
51 - 200 employees
🧬 Biotechnology
💊 Pharmaceuticals
🔥 Funding within the last year
💰 $400M Post-IPO Equity on 2026-09
Biotechnology • Pharmaceuticals
Tyra Biosciences is a clinical-stage biotechnology company developing precision medicines. It is advancing clinical studies of oral dabogratinib for skeletal dysplasia and urologic cancers.
🔥 3 minutes ago
Where this job comes from
Posted on Tyra Biosciences's careers page ↗, not through a job board
First seen by Remote Rocketship 3 minutes ago

51 - 200 employees
🧬 Biotechnology
💊 Pharmaceuticals
🔥 Funding within the last year
💰 $400M Post-IPO Equity on 2026-09
Biotechnology • Pharmaceuticals
Tyra Biosciences is a clinical-stage biotechnology company developing precision medicines. It is advancing clinical studies of oral dabogratinib for skeletal dysplasia and urologic cancers.
• Develop and execute comprehensive global regulatory strategies for a late-stage Skeletal Dysplasia program. • Lead regulatory strategy from late-stage development through global submissions, approvals, and post-approval lifecycle management. • Anticipate regulatory risks and proactively define mitigation strategies. • Lead global health authority interactions, including FDA, EMA, PMDA, MHRA, Health Canada, and emerging markets as appropriate. • Drive preparation for and participation in regulatory meetings, including EOP2, Scientific Advice, pre-NDA/MAA/JNDA. • Interpret and communicate regulatory feedback and translate it into actionable development and submission plans. • Serve as the regulatory strategy lead for a cross-functional Skeletal Dysplasia program team. • Partner with cross-functional partners to ensure integrated and executable regulatory plans. • Support accelerated development and registration pathways where applicable. • Provide strategic oversight for global marketing applications and major lifecycle submissions. • Ensure global alignment of indication, labeling, and regulatory positioning for Skeletal Dysplasia assets. • Guide regulatory input into summary documents and key scientific justifications. • Lead with urgency, accountability, and focus in a dynamic, high-growth biotech environment. • Balance strategic thinking with hands-on contribution to support critical program milestones. • Mentor and influence team members and stakeholders. • Be responsible for assigned activities with the project team. • Perform other duties as required.
• Bachelor’s degree in a scientific discipline; advanced degree (MS, PhD, PharmD, or MD) strongly preferred. • 10+ years of progressive experience in global regulatory strategy within the biotechnology or pharmaceutical industry. • Mandatory experience leading late-stage development and global registration for Skeletal Dysplasia products. • Demonstrated success with major global marketing applications (e.g., NDA/BLA/MAA) and health authority interactions. • Strong knowledge of global regulatory requirements and pathways for Skeletal Dysplasia drug development. • Proven ability to operate with urgency and make sound regulatory decisions in a fast-paced environment. • Experience supporting accelerated or innovative regulatory pathways in Skeletal Dysplasia. • Prior experience working on cross-regional global regulatory strategies. • Proven ability to lead teams, manage vendors, and execute complex regulatory programs in a dynamic environment. • Experience supporting both late-stage development and early commercial products. • Prior experience in a high-growth or emerging biotech environment. • Direct experience building or scaling regulatory operations capabilities. • Ability to communicate effectively in both a written and verbal format. • Ability to work both independently with minimal direction and within project teams to attain group goals. • Highly detailed with strong organization skills. • Ability to work well in a deadline-driven environment. • Team oriented person. • Fluent in spoken and written English. • Up to 20% travel may be required.
• Competitive base, bonus, new hire and ongoing equity packages • Employer-paid Medical, dental, and vision insurance • Employer-paid life insurance, AD&D, short-term disability, long-term disability, and EAP coverage • 401(k) Plan with a fully vested company match 1:1 up to 4% of contributions • Employee Stock Purchase Plan • 14 -18 paid holidays, including office closure between December 25th and January 1st • Flexible vacation • Sick time • Fitness Program • Get Outdoors Program • Paid parental leave benefit • Tuition assistance • Up to 20% travel may be required
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
🔥 10 minutes ago
CMC Regulatory Director leading global regulatory strategies, submissions, and lifecycle management for Revolution Medicines’ RAS-targeted oncology drugs. Advising cross-functional teams through clinical development and commercialization.
🇺🇸 United States – Remote
💵 $201k - $251k / year
🔥 Funding within the last year
💰 $500M POST IPO EQUITY on 2026-04
⏰ Full Time
🔴 Lead
🚔 Compliance
🔥 10 minutes ago
Associate Director guiding regulatory strategy for Revolution Medicines’ RAS oncology drug pipeline. Coordinating submissions, FDA/EMA compliance, risk mitigation, and cross-functional oncology development teams.
🇺🇸 United States – Remote
💵 $177k - $221k / year
🔥 Funding within the last year
💰 $500M POST IPO EQUITY on 2026-04
⏰ Full Time
🟠 Senior
🔴 Lead
🚔 Compliance
🔥 10 minutes ago
Associate Director leading global CMC regulatory strategy for Revolution Medicines’ oncology drug pipeline. Preparing worldwide submissions and guiding regulatory requirements across product development and commercialization.
🇺🇸 United States – Remote
💵 $177k - $221k / year
🔥 Funding within the last year
💰 $500M POST IPO EQUITY on 2026-04
⏰ Full Time
🔴 Lead
🚔 Compliance
🕒 Yesterday
Trade Compliance Manager leading FAAC/Ignium’s global export controls, customs, licensing, and sanctions compliance. Building scalable programs across aerospace and defense operations.
🕒 Yesterday
Associate Director leading facility compliance, VA contract compliance, and quality improvement for Leidos QTC Health Services. Managing compliance teams supporting healthcare examination and case management programs.